MAPI News
Archived Headlines
- Week ahead: Will 2016 see its first IPO? 01/22/16
- Enhanced generics biotech Mapi-Pharma sets terms again for $50 million IPO 01/22/16
- IPO market brought down by biotech wreck and market sell off 07/31/14
- Mapi-Pharma postpones $18 million IPO 07/29/14
- 22 US IPOs planned for the week of Jul 28 07/28/14
See more
Israeli drug developer Mapi-Pharma officially withdraws $50 million US IPO
Mapi-Pharma, which is developing extended-release formulations of existing drugs and generics, officially withdrew its plans for an initial public offering on Monday. The company originally filed to raise $40 million in an April 2014 IPO, postponed the offering,...read more
Week ahead: IPO market still stuck in neutral
The IPO market remains in the doldrums this week, but the Renaissance IPO Index's 10% gain in the past two weeks suggests that the IPO train could start rolling again in March. Second time's a charm After a scrapped IPO attempt in June 2014, ...read more
Week ahead: A microcap biotech and a SPAC
The IPO market continued at its snail's pace with only two pricing dates set and one initial filing for an up-listing this past week. The slowdown is to be expected around this time of year as companies update their year-end financials. Papa's special ...read more
Week ahead: Biotechs could snap IPO drought
February is kicking off with four potential biotech pricings, including heavy hitters Editas Medicine and BeiGene. These two IPOs could breathe life back into the IPO market after a deal-less January and a sharp decline in the Nasdaq Biotech Index (down 21%...read more